Simultaneous quantification of ginsenoside Rg1 and its metabolites by HPLC–MS/MS: Rg1 excretion in rat bile, urine and feces
Ginsenoside Rg1 (Rg1), the major effective component of ginseng, has been shown to have multiple bioactivities, but low oral bioavailability. The aim of this study was to develop a simple, sensitive and rapid high performance liquid chromatography–tandem mass spectrometry (LC–MS/MS) method, which co...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-10-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383516301769 |
_version_ | 1818422896776708096 |
---|---|
author | Chiyu He Ru Feng Yupeng Sun Shifeng Chu Ji Chen Chao Ma Jie Fu Zhenxiong Zhao Min Huang Jiawen Shou Xiaoyang Li Yuzhu Wang Jinfeng Hu Yan Wang Juntian Zhang |
author_facet | Chiyu He Ru Feng Yupeng Sun Shifeng Chu Ji Chen Chao Ma Jie Fu Zhenxiong Zhao Min Huang Jiawen Shou Xiaoyang Li Yuzhu Wang Jinfeng Hu Yan Wang Juntian Zhang |
author_sort | Chiyu He |
collection | DOAJ |
description | Ginsenoside Rg1 (Rg1), the major effective component of ginseng, has been shown to have multiple bioactivities, but low oral bioavailability. The aim of this study was to develop a simple, sensitive and rapid high performance liquid chromatography–tandem mass spectrometry (LC–MS/MS) method, which could be used to validate and quantify the concentrations of Rg1 and its metabolites in Sprague-Dawley rat bile, urine, and feces after oral administration (25 mg/kg). Calibration curves offered satisfactory linearity (r>0.995) within the determined ranges. Both intra-day and inter-day variances were less than 15%, and the accuracy was within 80–120%. The excretion recoveries of Rg1, ginsenoside Rh1 (Rh1), and protopanaxatriol (Ppt) in bile, urine, and feces combined were all greater than 70%. The fecal excretion recoveries of Rg1, Rh1, and Ppt were 40.11%, 22.19%, and 22.88%, respectively, whereas 6.88% of Rg1 and 0.09% of Rh1 were excreted in bile. Urinary excretion accounted for only 0.04% of Rg1. In conclusion, the observed excretion profiles for Rg1 and its metabolites after oral administration are helpful for understanding the poor oral bioavailability of Rg1 and will aid further investigations of Rg1 as a pharmacologically active component. |
first_indexed | 2024-12-14T13:33:33Z |
format | Article |
id | doaj.art-a6272b64f5ca4b60ab9cc8a2a6d64528 |
institution | Directory Open Access Journal |
issn | 2211-3835 2211-3843 |
language | English |
last_indexed | 2024-12-14T13:33:33Z |
publishDate | 2016-10-01 |
publisher | Elsevier |
record_format | Article |
series | Acta Pharmaceutica Sinica B |
spelling | doaj.art-a6272b64f5ca4b60ab9cc8a2a6d645282022-12-21T22:59:39ZengElsevierActa Pharmaceutica Sinica B2211-38352211-38432016-10-016659359910.1016/j.apsb.2016.05.001Simultaneous quantification of ginsenoside Rg1 and its metabolites by HPLC–MS/MS: Rg1 excretion in rat bile, urine and fecesChiyu He0Ru Feng1Yupeng Sun2Shifeng Chu3Ji Chen4Chao Ma5Jie Fu6Zhenxiong Zhao7Min Huang8Jiawen Shou9Xiaoyang Li10Yuzhu Wang11Jinfeng Hu12Yan Wang13Juntian Zhang14State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, ChinaState Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, ChinaState Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, ChinaState Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, ChinaState Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, ChinaBeijing Analytical Application Center, Shimadzu (China) Co., Ltd., Beijing 100020, ChinaState Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, ChinaState Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, ChinaState Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, ChinaState Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, ChinaState Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, ChinaState Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, ChinaState Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, ChinaState Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, ChinaState Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, ChinaGinsenoside Rg1 (Rg1), the major effective component of ginseng, has been shown to have multiple bioactivities, but low oral bioavailability. The aim of this study was to develop a simple, sensitive and rapid high performance liquid chromatography–tandem mass spectrometry (LC–MS/MS) method, which could be used to validate and quantify the concentrations of Rg1 and its metabolites in Sprague-Dawley rat bile, urine, and feces after oral administration (25 mg/kg). Calibration curves offered satisfactory linearity (r>0.995) within the determined ranges. Both intra-day and inter-day variances were less than 15%, and the accuracy was within 80–120%. The excretion recoveries of Rg1, ginsenoside Rh1 (Rh1), and protopanaxatriol (Ppt) in bile, urine, and feces combined were all greater than 70%. The fecal excretion recoveries of Rg1, Rh1, and Ppt were 40.11%, 22.19%, and 22.88%, respectively, whereas 6.88% of Rg1 and 0.09% of Rh1 were excreted in bile. Urinary excretion accounted for only 0.04% of Rg1. In conclusion, the observed excretion profiles for Rg1 and its metabolites after oral administration are helpful for understanding the poor oral bioavailability of Rg1 and will aid further investigations of Rg1 as a pharmacologically active component.http://www.sciencedirect.com/science/article/pii/S2211383516301769Ginsenoside Rg1Ginsenoside Rh1ProtopanaxatriolExcretionLC–MS/MS |
spellingShingle | Chiyu He Ru Feng Yupeng Sun Shifeng Chu Ji Chen Chao Ma Jie Fu Zhenxiong Zhao Min Huang Jiawen Shou Xiaoyang Li Yuzhu Wang Jinfeng Hu Yan Wang Juntian Zhang Simultaneous quantification of ginsenoside Rg1 and its metabolites by HPLC–MS/MS: Rg1 excretion in rat bile, urine and feces Acta Pharmaceutica Sinica B Ginsenoside Rg1 Ginsenoside Rh1 Protopanaxatriol Excretion LC–MS/MS |
title | Simultaneous quantification of ginsenoside Rg1 and its metabolites by HPLC–MS/MS: Rg1 excretion in rat bile, urine and feces |
title_full | Simultaneous quantification of ginsenoside Rg1 and its metabolites by HPLC–MS/MS: Rg1 excretion in rat bile, urine and feces |
title_fullStr | Simultaneous quantification of ginsenoside Rg1 and its metabolites by HPLC–MS/MS: Rg1 excretion in rat bile, urine and feces |
title_full_unstemmed | Simultaneous quantification of ginsenoside Rg1 and its metabolites by HPLC–MS/MS: Rg1 excretion in rat bile, urine and feces |
title_short | Simultaneous quantification of ginsenoside Rg1 and its metabolites by HPLC–MS/MS: Rg1 excretion in rat bile, urine and feces |
title_sort | simultaneous quantification of ginsenoside rg1 and its metabolites by hplc ms ms rg1 excretion in rat bile urine and feces |
topic | Ginsenoside Rg1 Ginsenoside Rh1 Protopanaxatriol Excretion LC–MS/MS |
url | http://www.sciencedirect.com/science/article/pii/S2211383516301769 |
work_keys_str_mv | AT chiyuhe simultaneousquantificationofginsenosiderg1anditsmetabolitesbyhplcmsmsrg1excretioninratbileurineandfeces AT rufeng simultaneousquantificationofginsenosiderg1anditsmetabolitesbyhplcmsmsrg1excretioninratbileurineandfeces AT yupengsun simultaneousquantificationofginsenosiderg1anditsmetabolitesbyhplcmsmsrg1excretioninratbileurineandfeces AT shifengchu simultaneousquantificationofginsenosiderg1anditsmetabolitesbyhplcmsmsrg1excretioninratbileurineandfeces AT jichen simultaneousquantificationofginsenosiderg1anditsmetabolitesbyhplcmsmsrg1excretioninratbileurineandfeces AT chaoma simultaneousquantificationofginsenosiderg1anditsmetabolitesbyhplcmsmsrg1excretioninratbileurineandfeces AT jiefu simultaneousquantificationofginsenosiderg1anditsmetabolitesbyhplcmsmsrg1excretioninratbileurineandfeces AT zhenxiongzhao simultaneousquantificationofginsenosiderg1anditsmetabolitesbyhplcmsmsrg1excretioninratbileurineandfeces AT minhuang simultaneousquantificationofginsenosiderg1anditsmetabolitesbyhplcmsmsrg1excretioninratbileurineandfeces AT jiawenshou simultaneousquantificationofginsenosiderg1anditsmetabolitesbyhplcmsmsrg1excretioninratbileurineandfeces AT xiaoyangli simultaneousquantificationofginsenosiderg1anditsmetabolitesbyhplcmsmsrg1excretioninratbileurineandfeces AT yuzhuwang simultaneousquantificationofginsenosiderg1anditsmetabolitesbyhplcmsmsrg1excretioninratbileurineandfeces AT jinfenghu simultaneousquantificationofginsenosiderg1anditsmetabolitesbyhplcmsmsrg1excretioninratbileurineandfeces AT yanwang simultaneousquantificationofginsenosiderg1anditsmetabolitesbyhplcmsmsrg1excretioninratbileurineandfeces AT juntianzhang simultaneousquantificationofginsenosiderg1anditsmetabolitesbyhplcmsmsrg1excretioninratbileurineandfeces |